Evidence map›Paper›PMID 28223459›Full record

ArticlemBio2017

Evolution and Epidemiology of Multidrug-Resistant

Danesh Moradigaravand, Veronique Martin, Sharon J Peacock, Julian Parkhill

Open access · goldAbstract read
In one paragraph

Article in mBio, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 138 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Emergence ofbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Antimicrobial resistance and virulence inAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  15. Molecular and virulence differences ofFrontiers in microbiology · 2025
    Article
  16. Molecular epidemiology of carbapenem-resistantFrontiers in microbiology · 2025
    Article
  17. Article
  18. Article
  19. Resistance Pattern ofMedicina (Kaunas, Lithuania) · 2024
    Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Danesh MoradigaravandWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
Veronique MartinBritish Society for Antimicrobial Chemotherapy, Birmingham, United Kingdom.
Sharon J PeacockWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom.
Julian ParkhillWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, United Kingdom parkhill@sanger.ac.uk.ORCID 0000-0002-7069-5958
Wellcome Sanger Institute · GBBritish Society for Antimicrobial Chemotherapy · GBUniversity of Cambridge · GB

Funding

Department of Health HICF-T5-342Wellcome Trust 098051Wellcome Trust WT098600
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug Resistance, Multiple, BacterialMolecular TypingPhylogenyGenetic VariationHospitalsHumansIrelandKlebsiella InfectionsKlebsiella pneumoniaeMolecular EpidemiologyUnited Kingdom

Identifiers

PMID28223459
PMCPMC5358916
OpenAlexW2590023769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.